Evidence behind this recommendation.
Selected studies from our library that inform the recommendations on this page. Evidence grade shown when available.
Gout: Monosodium Urate Crystal Arthritis
Gout is the most prevalent inflammatory arthritis in adults — affecting about 2–4% of the general population, with marked male predominance (10:1) and rising incidence associated with the Western diet, obesity, metabolic syndrome, and use of thiazide diuretics. It is caused by the deposition of monosodium urate (MSU) crystals in joints and soft tissues, triggering an intense acute inflammatory response mediated mainly by IL-1β via activation of the NLRP3 inflammasome.
The gout flare is one of the most intense joint pains in medicine — classically described as one of the most agonizing pains a person can experience. The treatment target is twofold: control of the acute flare (anti-inflammatory/analgesic) and prevention of future flares (urate-lowering).
Conventional Treatment of Gout
Treatment of gout is biphasic: acute control of the flare and chronic prevention with urate-lowering agents — with allopurinol being the cornerstone of preventive treatment.
PHARMACOTHERAPY OF GOUT — ACUTE AND PREVENTIVE PHASE
| PHASE | DRUG | MECHANISM | LIMITATION |
|---|---|---|---|
| Acute | NSAIDs (indomethacin, naproxen) | COX-2: reduction of prostaglandins | GI, renal, cardiovascular; contraindicated in CKD/HF |
| Acute | Colchicine 0.5 mg 2–3×/day | Inhibition of neutrophilic tubulin polymerization; blocks NLRP3 | Diarrhea, myalgia, myelosuppression in CKD; interaction with statins |
| Acute | Prednisone 30–40 mg/day × 5 days | Broad anti-inflammatory | Hyperglycemia; do not use in septic gout (confounds diagnosis) |
| Severe acute | Canakinumab (anti-IL-1β) | Specific blockade of the inflammasome | High cost; immunosuppression; reserved for refractory cases |
| Preventive | Allopurinol (xanthine oxidase inhibitor) | Reduces uric acid production | Rash (2%; DRESS in HLA-B*5801+); initiation may precipitate a flare |
| Preventive | Febuxostat (xanthine oxidase inhibitor) | More potent than allopurinol | Cost; cardiovascular risk warning in established CVD |
Mechanisms of Action in Gout
Acupuncture acts on the gout flare through direct anti-inflammatory mechanisms that converge with conventional pharmacological targets — especially the NLRP3 inflammasome/IL-1β pathway.
Anti-Inflammatory Mechanisms of Action in Gout
1. Inhibition of the IL-1β Pathway (NLRP3 Inflammasome)
MSU crystals activate the NLRP3 inflammasome in synovial macrophages → caspase-1 → IL-1β → explosive inflammatory cascade. Acupuncture at SP-9 and LI-11 reduces IL-1β by 42% and TNF-α by 38% (Inflammation Research, 2022) — converging with the mechanism of colchicine (which blocks NLRP3 via stabilization of microtubules) and canakinumab (direct blockade of IL-1β).
2. Reduction of Serum Uric Acid via ST-36 + SP-6
Meta-analyses show a uric acid reduction of 46 µmol/L with acupuncture at ST-36 + SP-6 — a modest but additive effect to allopurinol. The proposed mechanism is activation of renal purine metabolism (increased uricosuria) via modulation of the HPA axis and renal perfusion. It is a relevant complementary effect, although not sufficient to replace urate-lowering agents.
3. ST-34 (Xi-Cleft of the Stomach) — Acute Flare
The Xi-Cleft points of each meridian have intense acute and anti-inflammatory action along the pathway of that meridian. ST-34 (Xi-Cleft of the stomach meridian, which runs along the anterior aspect of the leg and dorsum of the foot) is the point of choice for acute gout in the 1st MTP and ankle — aligning with the most frequently affected anatomical territory.
4. KI-3 + LR-3 — Uric Acid Excretion
KI-3 (kidney) and LR-3 (liver) are points of organ support for urate elimination. The kidney eliminates 2/3 of uric acid; the liver processes xanthine into urate via xanthine oxidase. Modulation of these systems by acupuncture contributes modestly to long-term reduction of serum uric acid levels.
Acute Flare
- • SP-9 — anti-inflammation, "damp-heat"
- • LI-11 — anti-inflammatory, "heat"
- • ST-34 — Xi-Cleft, acute pain
- • Local periarticular points (2–3 mm)
Chronic Prevention
- • ST-36 — urate metabolism
- • SP-6 — systemic, kidney
- • KI-3 — renal function
- • LR-3 — hepatic metabolism
Local Points by Joint
- • 1st MTP (podagra): SP-1, LR-1, ST-44
- • Ankle: KI-3, BL-60, SP-5
- • Knee: SP-9, ST-35, BL-40
- • Wrist/hand: TE-4, SI-5, LI-4
Scientific Evidence
The 2021 meta-analysis (eBCAM) pooled 7 RCTs with 498 patients, covering both the acute phase and maintenance treatment for flare prevention.
COMPARATIVE RESULTS — ACUPUNCTURE VS. PHARMACOTHERAPY IN GOUT
| OUTCOME | ACUPUNCTURE | PHARMACOLOGICAL | QUALITY OF EVIDENCE |
|---|---|---|---|
| VAS pain (acute flare) | −3.2 pts | −2.8 pts (indomethacin) | Low-Moderate (7 RCTs) |
| Serum uric acid | −46 µmol/L additional | Allopurinol: −120 µmol/L | Low (complementary effect, not a substitute) |
| Flare frequency/year | −44% (monthly maintenance) | −60–70% (allopurinol on target <6 mg/dL) | Low-Moderate |
| Serum IL-1β | −42% | Colchicine: −38% | Low (small studies) |
| GI adverse effects | <2% | 48% (indomethacin GI) | Acupuncture better tolerated |
Clinical Protocol for Gout
Acute Phase and Maintenance
Acute Phase (Active Flare)
Acupuncture can be performed during an acute flare — it is analgesic and anti-inflammatory. Protocol: SP-9 + LI-11 (systemic anti-inflammatory), ST-34 (Xi-Cleft), local periarticular points (2–3 mm from the joint). Technique: rapid needling with qi sensation without excessive rotation (the inflamed joint is hypersensitive). Combine with colchicine if available.
Remission / Prevention Phase
One session/week for 4 weeks, then biweekly. Protocol: ST-36 + SP-6 + KI-3 + LR-3. Goal: additional reduction of uric acid and flare frequency. DO NOT replace allopurinol — keep it on target (<6 mg/dL, or <5 mg/dL in patients with tophi). Reassess uricemia every six months.
Essential Dietary Guidance
Reduce red meats, organ meats, seafood, alcohol (especially beer and spirits), fructose. Increase hydration (>2L/day) and skim dairy. Acupuncture does not replace dietary measures — both are complementary and potentiate the effect of allopurinol.
When to Seek Medical Acupuncture for Gout
Priority Indications
- • Acute flare with contraindication to NSAIDs (CKD, HF, anticoagulation)
- • Chronic gout with frequent flares despite allopurinol
- • GI intolerance to colchicine or NSAIDs
- • Gout + metabolic syndrome (acupuncture aids overall metabolism)
- • Patient who refuses or cannot use canakinumab
- • Gout in an elderly patient with polypharmacy
Important Guidance
- • Acupuncture does NOT replace allopurinol in chronic hyperuricemia
- • Start allopurinol OUTSIDE the flare (it may precipitate a flare at initiation)
- • Maintain prophylactic colchicine during the first 6 months of allopurinol
- • Always investigate septic arthritis in an acute febrile monoarticular case
- • Gouty tophus: acupuncture does not dissolve the tophus — surgical mechanical therapy if needed
Frequently Asked Questions
Frequently Asked Questions
Yes, provided the gout diagnosis has been confirmed and septic arthritis has been ruled out by the physician. During an acute flare, acupuncture can be used as complementary analgesia: we use fine needles 2–3 mm from the inflamed joint (not within it), combined with distal points of systemic anti-inflammatory action (SP-9, LI-11, ST-34). The analgesic response usually starts within 15–30 minutes, although it varies. A joint that is extremely hypersensitive to touch may require more peripheral and gentle needling.
No. The reduction in uric acid by acupuncture (−46 µmol/L, equivalent to −0.8 mg/dL) is complementary and insufficient as monotherapy for hyperuricemia. Allopurinol reduces uric acid by 3–5 mg/dL — far greater. Acupuncture can be a useful complement to close the gap needed to reach the target (<6 mg/dL) and to reduce flare frequency, but it should never replace urate-lowering therapy.
No. Tophi are solid deposits of monosodium urate crystals — they only dissolve with sustained reduction of serum uric acid below 6 mg/dL for months to years (treatment with allopurinol or febuxostat). Acupuncture does not dissolve tophi. For large tophi with ulceration or tendon compression, surgical treatment may be necessary.
The response to acupuncture is similar across any joint affected by gout. The protocol is adapted to the location: for the knee, SP-9, ST-35, BL-40, and periarticular points are used; for the great toe (podagra), SP-1, LR-1, ST-44, and LI-11 are used. The flare in the knee often has more effusion, and the larger joint makes periarticular needling easier.